JP2023515055A5 - - Google Patents
Info
- Publication number
- JP2023515055A5 JP2023515055A5 JP2022549793A JP2022549793A JP2023515055A5 JP 2023515055 A5 JP2023515055 A5 JP 2023515055A5 JP 2022549793 A JP2022549793 A JP 2022549793A JP 2022549793 A JP2022549793 A JP 2022549793A JP 2023515055 A5 JP2023515055 A5 JP 2023515055A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979309P | 2020-02-20 | 2020-02-20 | |
| US62/979,309 | 2020-02-20 | ||
| US202063044597P | 2020-06-26 | 2020-06-26 | |
| US63/044,597 | 2020-06-26 | ||
| US202163136134P | 2021-01-11 | 2021-01-11 | |
| US63/136,134 | 2021-01-11 | ||
| PCT/US2021/018868 WO2021168317A1 (en) | 2020-02-20 | 2021-02-19 | Inhibitory chimeric receptor architectures |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515055A JP2023515055A (ja) | 2023-04-12 |
| JPWO2021168317A5 JPWO2021168317A5 (https=) | 2024-02-29 |
| JP2023515055A5 true JP2023515055A5 (https=) | 2024-02-29 |
Family
ID=77391781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549793A Pending JP2023515055A (ja) | 2020-02-20 | 2021-02-19 | 阻害性キメラ受容体アーキテクチャ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230235051A1 (https=) |
| EP (1) | EP4107175A4 (https=) |
| JP (1) | JP2023515055A (https=) |
| CN (1) | CN115397845A (https=) |
| TW (1) | TW202144396A (https=) |
| WO (1) | WO2021168317A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022546315A (ja) * | 2019-08-20 | 2022-11-04 | センティ バイオサイエンシズ インコーポレイテッド | キメラ抑制性受容体 |
| CA3261358A1 (en) * | 2022-07-26 | 2024-02-01 | Senti Biosciences, Inc. | CHIMERIC RECEPTOR INHIBITOR ARCHITECTURES |
| WO2024238769A2 (en) * | 2023-05-16 | 2024-11-21 | The Regents Of The University Of California | Inhibitory chimeric antigen receptors that reduce car-t cell "on-target, off-tumor" toxicity |
| WO2025096730A1 (en) * | 2023-11-01 | 2025-05-08 | University Of Virginia Patent Foundation | Novel autoregulated car t cells and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448035B1 (en) * | 1997-04-24 | 2002-09-10 | Immunex Corporation | Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR) |
| US7265208B2 (en) * | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| WO2015142314A1 (en) * | 2013-03-15 | 2015-09-24 | Memorial Sloan-Kettering Cancer Center | Compositions and methods for immunotherapy |
| US20160296562A1 (en) * | 2013-11-21 | 2016-10-13 | Ucl Business Plc | Cell |
| US11072644B2 (en) * | 2014-11-12 | 2021-07-27 | Allogene Therapeutics, Inc. | Inhibitory chimeric antigen receptors |
| CA2969384A1 (en) * | 2014-12-17 | 2016-06-23 | Cellectis | Inhibitory chimeric antigen receptor (icar or n-car) expressing non-t cell transduction domain |
| EP3380602A4 (en) * | 2015-11-23 | 2019-09-25 | Trustees of Boston University | METHOD AND COMPOSITIONS RELATED TO CHIMERIC ANTIGEN RECEPTORS |
| CA3007258A1 (en) * | 2015-12-03 | 2017-06-08 | Mark L. Bonyhadi | Compositions and methods for reducing immune responses against cell therapies |
| MX2019003462A (es) * | 2016-09-28 | 2019-08-16 | Gavish Galilee Bio Appl Ltd | Una plataforma universal para el tratamiento con car que se dirige a una novedosa firma antigenica del cancer. |
| CN110582509A (zh) * | 2017-01-31 | 2019-12-17 | 诺华股份有限公司 | 使用具有多特异性的嵌合t细胞受体蛋白治疗癌症 |
| GB201707783D0 (en) * | 2017-05-15 | 2017-06-28 | Autolus Ltd | Cell |
| WO2019016784A1 (en) * | 2017-07-21 | 2019-01-24 | Universidade De Coimbra | ANTI-NUCLEOLIN ANTIBODIES |
| KR20200071740A (ko) * | 2017-09-28 | 2020-06-19 | 임팩트-바이오 리미티드. | 저해성 키메라 항원 수용체 (icar)를 제조하기 위한 보편적 플랫폼 |
| US11866731B2 (en) * | 2017-11-10 | 2024-01-09 | Chineo Medical Technology Co., Ltd | Modified immune cells and uses thereof |
| US20200316120A1 (en) * | 2018-09-28 | 2020-10-08 | Immpact-Bio Ltd. | METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIES |
| US20220170097A1 (en) * | 2018-10-29 | 2022-06-02 | The Broad Institute, Inc. | Car t cell transcriptional atlas |
| JP7739261B2 (ja) * | 2019-08-09 | 2025-09-16 | エイ２・バイオセラピューティクス・インコーポレイテッド | ヘテロ接合性の喪失に応答する細胞表面受容体 |
| JP2022546315A (ja) * | 2019-08-20 | 2022-11-04 | センティ バイオサイエンシズ インコーポレイテッド | キメラ抑制性受容体 |
| EP4073103A1 (en) * | 2019-12-11 | 2022-10-19 | A2 Biotherapeutics, Inc. | Lilrb1-based chimeric antigen receptor |
-
2021
- 2021-02-19 CN CN202180028773.9A patent/CN115397845A/zh active Pending
- 2021-02-19 JP JP2022549793A patent/JP2023515055A/ja active Pending
- 2021-02-19 WO PCT/US2021/018868 patent/WO2021168317A1/en not_active Ceased
- 2021-02-19 EP EP21756614.0A patent/EP4107175A4/en active Pending
- 2021-02-19 TW TW110105857A patent/TW202144396A/zh unknown
-
2022
- 2022-08-17 US US17/820,525 patent/US20230235051A1/en active Pending